2024

1. A genome-wide association meta-analysis of all-cause and vascular dementia

   Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 5973-5995

2. A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells

   npj Parkinson's Disease, Vol. 10, Núm. 1

3. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

   Alzheimer's Research and Therapy, Vol. 16, Núm. 1

4. Altered tubulin detyrosination due to SVBP malfunction induces cytokinesis failure and senescence, underlying a complex hereditary spastic paraplegia

   Aging Cell

5. Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort

   Neurology, Vol. 102, Núm. 8

6. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

   npj Parkinson's Disease, Vol. 10, Núm. 1

7. Behavioral therapy in migraine: Expanding the therapeutic arsenal

   European Journal of Neurology

8. Biallelic variants in SNUPN cause a limb girdle muscular dystrophy with myofibrillar-like features

   Brain, Vol. 147, Núm. 8, pp. 2867-2883

9. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

   Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6722-6739

10. Blood-based multivariate methylation risk score for cognitive impairment and dementia

    Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6682-6698

11. Brief cognitive test as a decision tool in Primary Care settings. Population and validation study

    Neurologia, Vol. 39, Núm. 9, pp. 781-791

12. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 6205-6220

13. Defining and assessing psychological frailty in older adults: a scoping review protocol

    BMJ Open, Vol. 14, Núm. 3

14. Definition and assessment of psychological frailty in older adults: A scoping review

    Ageing Research Reviews, Vol. 100

15. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

16. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

    Neurologia

17. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

18. Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation

    Brain, Vol. 147, Núm. 5, pp. 1899-1913

19. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

20. Frequency and Longitudinal Course of Behavioral and Neuropsychiatric Symptoms in Participants with Genetic Frontotemporal Dementia

    Neurology, Vol. 103, Núm. 8